Social science research contributions to Antimicrobial Resistance: Protocol for a scoping review by Lambert, Helen S et al.
                          Lambert, H. S., Vedadhir, A., & Rodrigues, C. (2020). Social science
research contributions to Antimicrobial Resistance: Protocol for a
scoping review . Systematic Reviews, 9, [24 (2020)].
https://doi.org/10.1186/s13643-020-1279-y
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s13643-020-1279-y
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMC at
https://doi.org/10.1186/s13643-020-1279-y . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
PROTOCOL Open Access
Social science research contributions to
antimicrobial resistance: protocol for a
scoping review
Abou Ali Vedadhir1,2 , Carla Rodrigues1 and Helen Lambert1*
Abstract
Background: Antimicrobial resistance (AMR) is an escalating global health issue with complex and dynamic
interdependencies, high uncertainty and decision stakes, multiple drivers and stakeholders with diverse values and
interests, and various aspects and outcomes. Addressing and combating this critical global challenge requires the
formation and establishment of an interdisciplinary research approach that goes beyond the biosciences principally
concerned with antimicrobial resistance to include other relevant natural and social sciences. The objective of this
study will be to review and map existing social science knowledge and literature relating to antimicrobial resistance.
Methods: The review team will undertake the scoping review using the Arksey and O'Malley methodological
framework and also the Joanna Briggs Institute methods manual. Publications in English (from 1998 onwards) will
be searched using several databases including PubMed/MEDLINE, Web of Science, Scopus, Anthropological Plus,
Sociological Abstracts, International Bibliography of the Social Sciences (IBSS), PsycINFO and EconLit. Grey
literature will also be searched (e.g. Google Scholar). Two reviewers will independently screen all citations, full-
text articles, and abstract data. Publication types will include original articles, editorials, commentaries, protocols,
and books in the social science research literature on AMR. All study designs (quantitative, qualitative, and mixed-
methods) will be included. A PRISMA Flow Diagram of search and study selection will be used to report final
figures on included and excluded studies. To provide a descriptive summary of the literature, data will be
collated, stored, and charted using Microsoft Excel software. The analysis will also involve identifying themes and
gaps in the existing literature and summarizing, describing and displaying all pertinent information using
thematic construction approaches including qualitative content analysis methods.
Discussion: This protocol describes a systematic method to identify, map, and synthesize social science research
evidence on antimicrobial resistance. By mapping evidence and identifying potential knowledge gaps where
further research is warranted, the resulting scoping review will provide useful insights for the design, implementation,
and reorientation of future research agendas on AMR at multiple levels.
Systematic review registration: This protocol has been registered with the Open Science Framework (OSF): https://osf.
io/hyaem.
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Background
Antimicrobial resistance (AMR) is widely regarded as one
of the escalating global public health challenges of the
21st century [1]. AMR is an evolutionary process whereby
microorganisms acquire the ability to withstand anti-
microbial drugs, thus making treatment of infections inef-
fective and increasing the risk of resistant microorganisms
spreading among people, animals, and the environment.
The global spread of AMR may compromise our ability to
treat existing and emerging common infectious diseases,
as well as undermine many other improvements in health
and sustainable development [2]. “Overuse” and “subopti-
mal use” of antimicrobials, including antibiotics in
humans, farmed animals and the environment, mobility of
human populations between regions and healthcare facil-
ities, poor infection control, inadequate sanitary condi-
tions and inappropriate food-handling are considered the
main factors leading to the emergence and spread of
AMR [3–7].
AMR is a growing, multifaceted public health problem
that results in increased prolonged illness, disability and
death for patients [4, 8]. Beyond all of these, AMR is
widely considered to pose a threat to the future of hu-
manity [9]. According to one estimate, if not curtailed,
deaths per year linked with AMR could rise to 10 mil-
lion by 2050 [10–12]. AMR also increases healthcare
costs with lengthier stays in hospitals and a growing re-
quirement for more intensive patient care [4, 12]. It has
also been predicted that the mortality from infections
subject to AMR could result in a reduction of 2% to
3.5% in global gross domestic product (GDP) in 2050,
amounting to between 60 and 100 trillion US dollars
worldwide [10, 11, 13]. According to the World Bank
[14], people and economies in low- and middle-income
countries (LMICs) will experience proportionately
greater suffering than high-income countries (HICs)
from reduced economic growth and global poverty
caused by AMR. Health policymakers recognise that bio-
medical and life sciences approaches alone are insuffi-
cient to address critical global issues as significant and
complex as AMR [15]. The adoption of a cross-sectoral
‘one-health’ or ‘eco-health’ approach has therefore been
widely advocated [16–19]. Others have argued for a
more ‘overtly interdisciplinary’ approach [20] or for an
‘extended peer community’ (engaged citizenry) approach
to the issue [21–24], going beyond ‘behaviour’ [25, 26],
‘resistance’ [27], ‘drugs and bugs’ [28], ‘academic tribes
and territories’ [29], and/or ‘disciplinary epistemic cul-
tures’ [30, 31].
Together with calls for multidisciplinary and interdis-
ciplinary research, AMR has been characterised as a so-
cial rather than a biological problem such that, ‘it
demands a social solution, one based on greater under-
standing, measurement, modelling, and ultimately
(re)shaping the social, political, and economic environ-
ment in which resistance develops and antibiotics are
used’ [32]. There have been numerous calls to address
the socio-cultural, economic, and political dimensions of
AMR through greater involvement of social scientists in
AMR research [25, 26, 33–45].
Yet, despite widespread agreement that social science
research could provide vital insights into the sociocul-
tural, economic, political, and organisational determi-
nants and consequences of AMR [41], the social science
literature on these issues is sparse and widely scattered
[46]. This scoping review, therefore, aims to identify, cat-
egorise, summarize, synthesize and map existing know-
ledge, literature and evidence from published social
science research addressing AMR. The available litera-
ture will be identified and synthesised in order to pro-
vide a map of current knowledge and to identify




The methodological approach draws on a scoping review
or scoping study framework. The general purpose of
conducting scoping reviews is to identify and map the
available evidence and to clarify key concepts/definitions
in the literature. It is an ideal tool to determine the
coverage of a body of literature on a given topic, or
within a research area, and to give a clear indication of
the volume of evidence or studies available, as well as a
detailed overview of its focus [47–49]. A scoping review
can also be used to provide a broad outline of a certain
topic or a given field (such as AMR), to examine how re-
search is conducted on a certain topic or field, to de-
velop a “concept map” of a particular concept or
approach in the literature—what it refers to, and what it
encompasses—and to map evidence in relation to time,
location, source (peer-reviewed or grey literature), and/
or origin (healthcare or other academic disciplines) [50].
In addition, scoping reviews can be useful to detect and
analyse gaps in the existing body of knowledge and lit-
erature. They can, moreover, contribute to rapid evi-
dence review in emerging fields or topics or to examine
emerging evidence when it is still unclear what other,
more specific, questions can be posed and valuably ad-
dressed by a more precise systematic review [49].
The present protocol has been registered within the
Open Science Framework (registration: https://osf.io/
hyaem) and is being reported in accordance with the
reporting guidance provided in the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses Proto-
cols (PRISMA-P) statement [51, 52] (see checklist in
Additional file 1). This study will be conducted as per
the methodological framework developed by Arksey and
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O'Malley [47], the methodology outlined in the Joanna
Briggs Institute Reviewers’ Manual [48] and reported as
per the PRISMA statement extension for scoping re-
views (PRISMA-ScR) [53].
The stages of the study will comprise:
(1) Identification of the research questions and
objectives
(2) Identification of relevant published studies and
documents
(3) Selection of studies and documents
(4) Extracting and charting the evidence and data
(5) Collating, summarising and disseminating the
results and identifying the implications of the study
findings for policy, practice, and research on AMR.
This protocol was drafted using the PRISMA-ScR
checklist and explanation, recently developed and revised
by an international research team [53] with the aim of
providing a rationale and an example of good reporting
for each item of a systematic scoping review.
Oversight of protocol development, inclusion/exclusion
criteria, and the review process will be provided by a
multi-disciplinary advisory group including experts from
medical anthropology, sociology, health economics, social
psychology, health policy, and health services research.
Stage one: identification of the research question(s) and
objectives
As mentioned above, the main aim of this scoping re-
view is to identify, categorise, summarize, synthesize and
map existing knowledge, literature and evidence from
published social science research addressing AMR. More
specifically, the review will be guided by the following
research questions:
 What evidence or studies are available in the social
science research literature that address AMR?
 What empirical, conceptual and theoretical elements
constitute this body of literature?
 What knowledge and research gaps can be identified
in the literature?
Stage two: identification of relevant published studies/
literature
Eligibility criteria To find and categorise all studies or evi-
dence relevant to this review, the review team will search
relevant databases (listed below) of published literature. Out-
puts will be included if they are: published from 1998 on-
wards, when the first major UK government review on
AMR, “The Path of Least Resistance” was completed [54];
written and published in English only; addressing the
phenomenon of evolving microbial resistance to existing
antibiotic, antimicrobial or antifungal drugs; using social sci-
ence approaches and/or methodologies [55], with social sci-
ences defined as the disciplines included in the UK
Economic and Social Research Council (UK ESRC)’s list [56].
Publication types will include original research articles, re-
views, commentaries, short communications of findings,
books and book chapters, protocol papers, theory/discussion
papers, and editorials. Book reviews, wiki articles, blogs, web-
sites, practice guidelines, leaflets and brochures, policy state-
ments, reports on scientific meetings, and corporate
literature and data will be excluded. All research designs
(quantitative, qualitative, and mixed-methods studies) will be
included. Studies and documents focused solely on clinical,
biomedical, veterinary and microbiological aspects, mecha-
nisms or processes of AMR will be excluded. Studies will also
be included if they address human lives or life experiences,
practices, organisations or structures associated with AMR
and its drivers in non-human settings or subjects (e.g. veter-
inary or environmental aspects), but studies in animals,
plants, or the natural environment will be excluded. As
shown in Table 1, the Setting, Perspective, Intervention,
Comparison, Evaluation (SPICE) framework [57, 58] is used
to develop and outline inclusion/exclusion criteria and to
frame the review questions. Reasons for inclusion of all rele-
vant evidence will be documented at full-text review stage.
Information sources Potentially relevant studies, pub-
lished in English between 1st January 1998 and 30th
September 2019, will be searched in electronic data-
bases and other relevant grey literature sources. The
primary source of literature will be a structured
search of major electronic databases and will include:
Web of Science Core Collection; PubMed including
Medline; Scopus; Sociological Abstracts; The Inter-
national Bibliography of the Social Sciences (IBSS);
Anthropological Plus; PsycINFO and EconLit. The
secondary sources for searching grey or difficult to lo-
cate literature will include Google (Google Scholar
and Google Books), Open Grey, ProQuest, and world-
widescience.org. Hand searches of the reference lists
of included studies, reviews or other relevant docu-
ments, will be performed to identify additional rele-
vant publications that may not be directly indexed in
itemised sources. Content experts and authors who
are prolific in the field will also be contacted. The lit-
erature searches will be designed and conducted by
the review team in collaboration with two trained in-
formation specialists. The search will include a com-
prehensive range of terms and keywords related to
social science disciplines, specific approaches and
methodologies in social science research, and anti-
biotic, antimicrobial or drug resistance. For social sci-
ence disciplines, as mentioned above, the search will
adapt definitions from the UK ESRC’s list [56]. A
Vedadhir et al. Systematic Reviews            (2020) 9:24 Page 3 of 7
draft search strategy for Web of Science is provided
in Additional file 2. The final search results will be
exported into EndNote X9 and all duplicates will be
detected and then eliminated.
Stage three: selection of studies and documents
A two-stage selection process will be adopted consisting
of an initial screening based on title and abstract only,
followed by a full-text review of included items. All titles
and abstracts retrieved in the search will be read,
reviewed, and validated independently by two members
of the research team. Documents not meeting the de-
fined eligibility criteria will be excluded from full-text
analysis.
Two reviewers will independently analyse the content
of included full-text articles. The selected studies will be
reread and re-evaluated by a third reviewer in cases of
uncertainty or disagreement, and decisions about the eli-
gibility of a publication resolved through discussion to
reach consensus.
Table 1 Study details, characteristics, and results extraction instrument
Scoping review title: Social science research contributions to antimicrobial resistance: a scoping review
Review objective/s: To identify, categorise, summarize, synthesize and map out existing knowledge,
literature and evidence on AMR from social sciences research
Review question/s: • What evidence or studies are available that address social, cultural, organizational,
political or economic dimensions of AMR?
• What empirical, conceptual and/or theoretical elements constitute this body of literature?
• What knowledge and research gaps can be identified?
Concepts (what*): AMR, Social Sciences
Population (for whom*): Humans (excluding studies conducted in animals and plants)
Core concept: Social science research contributions to AMR
Language: English
Date of publication: January 1998–September 2019





Type of publication/source (e.g. commentary/peer-reviewed journal)
Year and place of publication:
Aim(s)/research question(s):
Type of study and/or methodological approach (including data collection methods and analytical approach, if available)
Academic discipline/disciplinary approach (e.g. sociology, anthropology, economics):
Location (where*) (e.g. country/province; rural/urban; country income level):
Context (if applicable) (e.g. patients’ home, primary/secondary/tertiary healthcare, pharmacies/ drug shops, farms, local/national/international policy):
Sample size (if applicable):
Year(s) of data collection:
Other results extracted from study or document content
Conceptual/theoretical framework or approach:
Domains addressed/focus of study
(e.g., prescribing, consuming or dispensing practices, social interactions including user—prescriber and/or professional—institutional interactions,
formal/informal aspects, stockholders, contextual factors, drivers, costs and impacts, socio-cultural meanings, images and stigma, intervention develop-
ment or evaluation, etc.);
Key findings that relate to the scoping review question(s) (*what result):
Comments on gaps, inconsistencies, biases and unmet needs in AMR research:
Reported AMR-related academic activities
(e.g., research and teaching programs, fellowships, funded projects; NGOs and networks; program and policy development, campaigns, advocacy, and
knowledge exchange activities, regulation and delivery on AMR, etc.):
Other emerging information or themes (*what else):
*Components of the SPICE framework: Setting (where); Perspective/Population (for whom); Intervention/Phenomena of Interest (what); Comparison (what else);
Evaluation (what result or how well)
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Stage four: extracting and charting the evidence and data
A standardised data abstraction template has been devel-
oped, adapted from the JBI Template extraction instru-
ment [48]. The template will be used to extract data
from full-text articles and other sources which meet the
eligibility criteria (see Table 1). Two members of the re-
search team will undertake data extraction and will re-
view the completed template for each item. Any
disagreements will be resolved through discussion and,
when necessary, independent validation by the third re-
viewer (PI).
Piloting of the data abstraction template will be achieved
through independent data extraction of three downloaded
eligible articles purposively selected to be diverse in con-
tent by all members of the research team, followed by
comparison and discussion to reach consensus on any
modifications needed. At intervals during the data extrac-
tion and charting process, charted data will be compared
and discussed to ensure consistency between reviewers
and to enable iterative reflection on emerging themes and
categories.
Stage five: collating, summarising and disseminating the
results and identifying the implications of the study
findings for policy, practice and research on AMR
A flow diagram, developed in line with PRISMA-ScR guid-
ance [53], will be used to report the review searching and in-
clusion/exclusion pathway. To provide a descriptive
summary of the literature, data will be collated, stored and
charted using Microsoft Excel software. An empirical ap-
proach will be taken for descriptive characteristics (e.g. study
type, method, location) but a narrative and flexible strategy
will be employed in summarizing and synthesizing review
findings on domains addressed and conceptual frameworks
identified in the retrieved literature. To quantitatively de-
scribe characteristics of the included studies, key information
or categories will be extracted from each source and pre-
sented using a variety of descriptive techniques including
summary and frequency tables, graphs (e.g. Bubble Plot) and
study matrices. Additionally, the analysis will involve identify-
ing themes and gaps in the existing literature (both quantita-
tive and qualitative) and summarising, describing and
displaying all pertinent information using thematic construc-
tion approaches including content analysis methods. A nar-
rative approach will be employed to describe themes that
emerge from the extracted data; topics will be grouped by
meaning and classified into coherent, relevant and clearly de-
fined themes by two reviewers. The results will be compared
and consolidated through accord between the two reviewers
and the principal investigator (PI).
Quality assessment and risk of bias
The purpose of this scoping review is to recognise all
the existing evidence or studies on the social science
research literature that address AMR. As such, study
quality or a formal risk of bias will not be assessed, nor
will it be used as a basis for exclusion of studies. This is
consistent with relevant guidance [47, 53].
Discussion
By systematically mapping existing social science re-
search evidence on antimicrobial resistance and identify-
ing potential knowledge gaps where further research is
warranted, this scoping review will provide useful in-
sights for the design, implementation, and orientation of
future multi- and inter-disciplinary research on the glo-
bal challenge of AMR at multiple levels: local, provincial,
national, and global. The methodological process, key re-
sults, insights, and implications of this review may be of
interest for diverse audiences and stakeholders inside
and outside academia, including researchers, academics
and policy-makers in a wide range of relevant fields be-
yond social sciences, given current acknowledgement of
the relevance and value of social science research in ad-
dressing the complex global problem of AMR.
This review has several potential limitations. Although
it acknowledges the need for ‘one-health’ or ‘eco-health’
interdisciplinary approaches to AMR, only publications
relating to human populations, behaviours, and experi-
ences (albeit including those which may influence envir-
onmental and veterinary aspects of AMR) will be
included. Despite following well-recognised sources such
as the UK ESRC and drawing on the expertise of re-
searchers from a range of disciplines, determining what
constitutes the content and scope of social sciences on
the one hand and their contributions to AMR on the
other is challenging. Increasing interdisciplinarity in the
health sciences and the adoption of methods from the
social sciences into a variety of other disciplines add to
the difficulties of agreeing terminology and applicability
and may result in the inadvertent exclusion of some
relevant sources of evidence. Additionally, the lack of
clarity in some studies regarding the disciplinary ap-
proach being taken may have implications for analytical
categorisation of those contributions. The analysis of
findings will take all these issues into consideration. The
review team also acknowledges that social science re-
search contributions to understanding AMR in societal
context are not limited to published papers that directly
address the problem of resistance (for instance, the sub-
stantial body of sociological and anthropological litera-
ture on medicines and pharmaceuticalisation is clearly
relevant). A thorough approach to the literature, how-
ever, required narrowing down the selection criteria for
this scoping review and these related literatures have
been widely discussed previously. The review team be-
lieves this approach will improve the quality of the out-
comes of this project.
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Ethical approval is not required as this scoping review
solely entails secondary analysis of previously collected
and publicly available publications and materials. How-
ever, the ethical precepts of copyright and intellectual
property will be respected. During the review process,
any amendments to the protocol that are deemed neces-
sary by the review team will be recorded in the master
protocol document and the reasons for the amendment
noted on file; outputs reporting the review results will
report any such amendments. The results of this review
will be disseminated through peer-reviewed publications
and presented at national and international conferences,
targeting audiences interested or involved in research
into AMR with a social science research approach.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13643-020-1279-y.
Additional file 1. PRISMA-P 2015 Checklist.
Additional file 2. Search Strategy.
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